Sorrento Therapeutics Files for Bankruptcy Following Legal Dispute with NantPharma LLC COVID-19 drug and vaccine developer, Sorrento Therapeutics, has filed for bankruptcy after losing an arbitration...
Scilex Holding Company, a subsidiary of Sorrento Therapeutics, has announced the acquisition of the rights to ELYXYBTM (celecoxib oral solution), the only FDA-approved ready-to-use oral solution...
With the FOMC meeting and Press Conference this week on Wednesday, July 27th and big tech reporting earnings throughout the week, traders are turning there attention...
NASDAQ stock SRNE has been given FDA clearance to proceed with a phase 1 clinical trial for their Covid-19 candidate, STI-2020. STI-2020 is a monoclonal antibody...
Recent Comments